CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ

Insider Sentiment (TTM):

Last Purchase:2023-06-28Last Sale:2025-02-19Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:96,765Shares Outstanding:3,696,668Institutional Ownership Pct.:2.62%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	-	-	-	-	-	-	-	-	-	-	3	-
Cash And Cash Equivalents At Carrying Value	9	6	7	5	7	8	6	6	7	9	3	5
Certificates Of Deposit At Carrying Value	-	-	-	-	-	-	-	-	-	-	-	7
Investments	-	-	-	-	-	-	0	0	0	0	7	-
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Notes Receivable Net	0	0	0	-	-	-	0	-	-	-	-	-
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	9	6	7	5	7	8	6	6	8	9	10	12
Other Assets
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0
Finite Lived Intangible Assets Net	0	0	0	0	0	0	1	1	0	0	0	0
Assets	9	6	8	6	7	8	7	7	8	10	11	13
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	0	0	0	0	0	0	0	0	0	0	0
Accrued Liabilities Current	-	-	0	0	0	0	0	0	0	0	0	0
Liabilities Current	1	0	0	0	0	0	0	0	0	0	0	0
Liabilities	1	0	0	0	0	0	0	0	0	0	0	0
Commitments And Contingen…
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	-	0	0	0	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	82	78	78	74	74	74	71	70	70	70	70	70
Retained Earnings Accumulated Deficit	-74	-72	-71	-69	-67	-66	-65	-63	-62	-60	-59	-57
Treasury Stock Common Value	-0	-0	-0	-0	-0	-0	0	-0	-0	-0	-0	-
Stockholders Equity	9	6	8	6	7	8	6	7	8	9	10	12
Treasury Stock Value	-	-	-	-	-	-	-	-	-	-	-0	-0
Minority Interest	0	0	0	-	-	-	0	-	-	-	-	-
Liabilities And Stockholders Equity	9	6	8	6	7	8	7	7	8	10	11	13
Common Stock No Par Value	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-
Common Stock Shares Authorized	25	25	25	25	25	25	5	5	5	5	5	5
Preferred Stock Shares Outstanding	-	-	-	-	0	-	-	-	-	-	-	-
Common Stock Shares Issued	6	4	4	3	3	3	2	1	1	1	1	1
Shares Outstanding	6	4	4	3	3	3	2	1	1	1	1	1
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	-	0.001	0.001	0.001	-	0.001	-
Preferred Stock Shares Authorized	10	10	10	10	10	-	10	10	10	-	10	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-2.60%	-48.05%	-64.93%	-	-	-	-	-	-	-	-	-
2025	1.87%	23.83%	26.63%	-4.50%	-0.75%	46.55%	-10.93%	-30.46%	-30.46%	16.30%	25.54%	11.96%
2024	0.00%	-11.49%	-16.55%	19.18%	2.05%	11.30%	-5.16%	-17.79%	-13.52%	-29.36%	-38.84%	-33.33%
2023	-	-	-	-11.51%	-4.84%	-15.28%	4.94%	9.41%	0.12%	0.39%	-16.18%	-15.51%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	12.91	19.69	25.97	20.71	23.89	27.39	18.73	19.13	20.21	23.54	27.65	28.60
Quick Ratio	12.63	18.95	25.49	20.57	23.57	26.90	18.13	18.92	19.86	23.04	26.89	28.43
Working Capital	8.32M	5.75M	7.11M	5.15M	6.36M	7.56M	5.81M	6.00M	7.23M	8.81M	9.90M	11.62M
Leverage & Debt
Debt to Equity	0.08	0.05	0.04	0.05	0.04	0.04	0.05	0.05	0.05	0.04	0.04	0.03
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-112,402.64	-202,524.60
Debt Ratio	0.07	0.05	0.04	0.04	0.04	0.03	0.05	0.05	0.05	0.04	0.03	0.03
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.63	-1.56	-2.52	-2.31	-2.23	-3.07	-3.71	-3.82	-3.29	-2.94	-2.97	-6.09
Free Cash Flow Per Share TTM	-0.91	-1.51	-1.58	-2.27	-2.20	-2.32	-3.03	-3.67	-3.96	-3.62	-5.68	-6.86
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-208,004.40%	-198,049.63%	-102,380.23%	-101,379.43%	-98,656.77%	-44,865.66%	-52,216.92%	-51,181.51%	-35,667.51%	-62,557.88%	-62,445.91%	-41,163.54%
Net Profit Margin TTM	-201,355.37%	-192,066.27%	-99,916.80%	-99,356.80%	-96,093.48%	-43,500.24%	-49,940.74%	-48,345.28%	-27,233.37%	-46,378.56%	-46,493.88%	-35,453.52%
Growth Metrics
Net Revenue Growth (1Y)	-50.00%	-78.57%	-45.45%	-45.45%	-64.71%	55.56%	22.22%	-55.28%	-76.90%	-87.77%	-89.84%	-82.14%
Net Income Growth (1Y)	4.77%	-5.39%	9.13%	12.10%	24.54%	45.90%	31.28%	-39.02%	-38.77%	-49.40%	-49.90%	45.05%
EPS Growth (1Y)	-58.31%	-33.91%	-48.45%	-37.95%	-31.07%	-19.24%	7.46%	-39.02%	-38.77%	397.64%	282.67%	1,325.91%
Valuation Metrics
P/E TTM	-1.56	-1.32	-1.21	-1.44	-1.19	-0.92	-0.74	-0.83	-1.19	-1.79	-1.58	-0.81
P/B TTM	1.09	1.25	0.96	1.54	1.00	0.70	0.64	0.68	0.72	0.81	0.64	0.58
P/S TTM	3,140.22	2,541.81	1,209.21	1,434.97	1,141.94	400.76	367.17	403.30	324.11	828.46	733.05	286.23
Market Cap	9.42M	7.63M	7.26M	8.61M	6.85M	5.61M	4.04M	4.44M	5.51M	7.46M	6.60M	7.04M
Enterprise Value	706.55K	1.90M	47.14K	3.23M	297.54K	-2.09M	-1.90M	-1.82M	-1.96M	-1.55M	3.13M	2.53M
Calculated Values
Free Cash Flow TTM	-5.90M	-5.59M	-5.86M	-5.87M	-5.69M	-6.00M	-5.30M	-5.25M	-5.67M	-5.18M	-8.13M	-9.82M
Net Debt	-8.71M	-5.72M	-7.21M	-5.38M	-6.55M	-7.70M	-5.94M	-6.26M	-7.47M	-9.01M	-3.47M	-4.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-02-19Sale

Owner: Finger, Michael H.

Title: -

Shares: 750

Price/Share: $5.75

Value: $4,312.50

Shares Owned: 351

Relationship: Director

Ownership: Direct

2023-06-28Purchase

Owner: Warbington, Timothy

Title: President & CEO

Shares: 200

Price/Share: $4.36

Value: $872.00

Shares Owned: 12,209

Relationship: Director,Officer

Ownership: Direct

2022-11-22Purchase

Owner: Warbington, Timothy

Title: President & CEO

Shares: 10,000

Price/Share: $0.38

Value: $3,800.00

Shares Owned: 112,087

Relationship: Director,Officer

Ownership: Direct

2022-09-27Purchase

Owner: Warbington, Timothy

Title: President & CEO

Shares: 20,000

Price/Share: $0.50

Value: $10,000.00

Shares Owned: 87,087

Relationship: Director,Officer

Ownership: Direct

2022-09-27Purchase

Owner: Finger, Michael H.

Title: -

Shares: 2,000

Price/Share: $0.50

Value: $1,000.00

Shares Owned: 18,502

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-02-19	Finger, Michael H.	Director	-	Direct	Sale	750	5.75	$4,312.50	351	4
2023-06-28	Warbington, Timothy	Director,Officer	President & CEO	Direct	Purchase	200	4.36	$872.00	12,209	4
2022-11-22	Warbington, Timothy	Director,Officer	President & CEO	Direct	Purchase	10,000	0.38	$3,800.00	112,087	4
2022-09-27	Warbington, Timothy	Director,Officer	President & CEO	Direct	Purchase	20,000	0.50	$10,000.00	87,087	4
2022-09-27	Finger, Michael H.	Director	-	Direct	Purchase	2,000	0.50	$1,000.00	18,502	4
2022-09-22	Warbington, Timothy	Director,Officer	President & CEO	Direct	Purchase	12,000	0.54	$6,480.00	67,087	4
2022-06-14	Finger, Michael H.	Director	-	Direct	Purchase	10,000	0.70	$7,000.00	16,502	4
2022-06-06	Warbington, Timothy	Director,Officer	President & CEO	Direct	Purchase	25,000	0.92	$23,000.00	25,087	4
2022-05-20	Finger, Michael H.	Director	-	Direct	Purchase	6,500	1.50	$9,750.00	6,502	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

2.62%

Inst. Shares: 96,765

Shares Outstanding: 3,696,668

2025-12-31

3.49%

Inst. Shares: 128,861

Shares Outstanding: 3,696,668

2025-09-30

2.59%

Inst. Shares: 66,724

Shares Outstanding: 2,580,532

2025-06-30

2.67%

Inst. Shares: 68,818

Shares Outstanding: 2,580,532

2025-03-31

7.31%

Inst. Shares: 188,548

Shares Outstanding: 2,580,532

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	96,765	3,696,668	2.62%
2025-12-31	128,861	3,696,668	3.49%
2025-09-30	66,724	2,580,532	2.59%
2025-06-30	68,818	2,580,532	2.67%
2025-03-31	188,548	2,580,532	7.31%
2024-12-31	29,860	1,748,428	1.71%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) — SEC Financial Statements & Analysis

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is a biological products, (no diagnostic substances) company, incorporated in NV. CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. trades on Nasdaq as: CELZ. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported a -50.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.08x, a Price-to-Sales (P/S) ratio of 3140.22x (TTM), a Price-to-Book (P/B) ratio of 1.09x (TTM), at a market cap of $9.42M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -50.00%
Debt To Equity: 0.08x
P/S TTM: 3140.22x
P/B TTM: 1.09x
Market Cap: $9.42M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. in?

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) operates in the Biological Products, (No Diagnostic Substances) industry.

What is CELZ's market cap?

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a market capitalization of $9.42M as of 2026-06-30.

What exchange does CELZ trade on?

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) trades on the Nasdaq.

Where is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. incorporated?

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is incorporated in NV.